Glossary of Retatrutide Research Terminology

Retatrutide listings, spec sheets, and forum threads all lean on a shared set of terms, and this glossary of retatrutide research terminology collects the ones that come up most often, grouped by what they describe rather than listed alphabetically. The goal is a reference a reader can return to when a listing uses a word without defining it, whether that word describes the molecule itself, how it is packaged, or how a vial’s numbers are calculated.

Naming and Identification Terms

Retatrutide is the international nonproprietary name (INN) assigned to this specific peptide sequence. Before a compound receives an INN, it is often referenced by a code name assigned during development — retatrutide’s code name, LY3437943, still shows up in older listings and archived spec sheets alongside the INN. Both terms point to the same molecule; the code name is simply the earlier label.

A sequence refers to the specific order of amino acids that make up the peptide. Two compounds can share a receptor-target profile and still be different molecules if their sequences differ, so a spec sheet that lists the sequence is giving more precise identifying information than the name alone provides.

An analog is a molecule that is structurally related to a reference compound but modified at one or more points in its sequence. Retatrutide is sometimes described in comparison charts as an analog relative to earlier single- or dual-target compounds, meaning it shares design lineage without being identical to them.

Receptor and Mechanism Terms

Retatrutide’s classification rests on a small set of terms describing what it binds and how.

An agonist is a molecule that binds a receptor and activates it, producing the same category of downstream signal the receptor’s natural ligand would trigger. This is different from an antagonist, which binds a receptor without activating it, blocking the site instead.

Triple agonist describes a molecule engineered to act as an agonist at three separate receptor types. For retatrutide, those three targets are the GLP-1 receptor, the GIP receptor, and the glucagon receptor — each named for the natural signaling molecule it normally responds to. Listings sometimes shorten this to “triple-G” or spell out all three receptor names; both refer to the same classification.

Receptor-count terminology follows a consistent pattern across this compound family: single agonists bind one receptor, dual agonists bind two, and triple agonists bind three. The table below summarizes how that pattern maps onto naming conventions used in retatrutide research terminology.

Term	What it describes
Agonist	Binds a receptor and activates it
Triple agonist	Agonist activity at three receptor types
GLP-1 / GIP / glucagon receptor	The three receptor targets named in retatrutide’s classification
INN	The standardized name assigned to the compound (retatrutide)
Code name	An earlier development-stage label (LY3437943)
Sequence	The specific order of amino acids in the peptide
Lyophilized	Freeze-dried into a stable powder form
Reconstitution	Adding liquid to a lyophilized vial to return it to solution
Concentration	The amount of peptide per unit volume once reconstituted
Purity	The proportion of a sample made up of the intended peptide

Formulation and Handling Terms

Retatrutide is typically supplied as a lyophilized powder — freeze-dried so the peptide remains stable without refrigeration until it is put into solution. Reconstitution is the process of adding a liquid, usually bacteriostatic water, to that powder so it becomes a usable solution again. Bacteriostatic water is water that includes a small amount of benzyl alcohol to inhibit bacterial growth across repeated draws from the same vial, which distinguishes it from plain sterile water.

Concentration describes how much peptide is present per unit of liquid volume after reconstitution, usually expressed in milligrams per milliliter (mg/mL). Concentration is calculated by dividing the total peptide mass in the vial by the volume of liquid added, and it is one of the few terms in this glossary that maps directly onto arithmetic a reader can check.

As a worked example: a vial labeled 5 mg, reconstituted with 2 mL of bacteriostatic water, has a concentration of 5 mg ÷ 2 mL = 2.5 mg/mL. Since 1 mg equals 1000 mcg, that same concentration is 2500 mcg/mL. On a U-100 insulin syringe, where 1 mL corresponds to 100 marked units, each unit on the syringe barrel holds 2500 mcg ÷ 100 units = 25 mcg. Changing the amount of liquid added changes this figure directly — more diluent lowers the concentration and the amount represented by each syringe unit, while less diluent raises both. A calculator such as peptcalc.com can be used to check this kind of conversion against a specific vial’s own label numbers.

Spec Sheet and Vial Label Terms

Purity refers to the proportion of a sample that consists of the intended peptide, as opposed to residual solvents, related impurities, or degradation products, and is usually reported as a percentage on a certificate of analysis. Molecular weight and molecular formula describe the mass and atomic composition of the peptide itself, and are useful for cross-checking that two listings under different names refer to the same molecule. A lot number or batch number identifies a specific production run, which matters when a certificate of analysis is tied to one batch rather than to the compound generally.

Catalogues that keep this vocabulary consistent from one spec sheet to the next make cross-referencing faster, since a reader does not have to re-derive what a term means every time it appears in a new listing — a research catalogue such as HEEZ Research that carries multiple compounds under one consistent naming scheme is useful precisely because it gives a reader a fixed reference point across entries, rather than a single spec sheet in isolation. Reading the terminology and the numeric spec side by side is what turns a glossary entry into something checkable against an actual vial label.

Why Consistent Terminology Matters

Different sources do not always use these terms the same way. Some spec sheets spell out all three receptor targets by name; others rely on the “triple agonist” shorthand and assume the reader already knows what it implies. Some listings state concentration directly in mg/mL; others give only the vial’s total mass and the suggested reconstitution volume, leaving the reader to calculate concentration themselves. Knowing the underlying terms — and how they relate to each other, as with reconstitution volume and concentration — makes it possible to translate between these different presentation styles without losing information or misreading a number.

This matters most at the boundary between naming and math. A term like “triple agonist” is purely descriptive and carries no numeric content, while a term like “concentration” is defined by a calculation. Treating the two the same way, or assuming a descriptive term implies a specific number, is a common source of confusion when comparing listings across multiple sources.

Summary

This glossary of retatrutide research terminology groups the vocabulary into three categories: naming and identification terms that specify which molecule is being discussed, receptor and mechanism terms that describe what the molecule binds, and formulation and handling terms that describe how it is packaged and reconstituted. Reading a spec sheet or vial label against this vocabulary — and checking the arithmetic behind terms like concentration — makes it easier to compare listings accurately across different sources.